ACIU — AC Immune AG Share News
0.000.00%
Last trade - 00:00- $249.35m
- $163.15m
- CH₣3.57m
Brief: Ac Immune Reports Positive Safety & Immunogenicity At Week-100 In Part 1 Of Vacsyn Phase 2 Trial Of Aci-7104
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health
Brief: AC Immune - Full Week-100 Results From Part 1 VacSYn Trial Expected In H2 2026
AC Immune jumps after US FDA grants fast-track status for Parkinson's disease drug
AC Immune SA reports results for the quarter ended June 30 - Earnings Summary
Brief: Ac Immune First Half 2026 Financial And Corporate Update
Swiss stocks - Factors to watch on August 3
Brief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Rivian, Biohaven, CervoMed
Brief: AC Immune Presents First In Vivo Images Of Brain Tdp-43 Pathology From Phase 1 Trial Of Pet Tracer Aci-19626, At Ad/Pdtm 2026
U.S. STOCKS ON THE MOVE-Alibaba, Accenture, energy companies
AC Immune rises as early data shows new brain scan can spot dementia protein
Swiss stocks - Factors to watch on March 11